For laboratory research use only. Not for human or veterinary use. Read our research-use policy

Manufacturing

Solid-phase peptide synthesis (SPPS) explained

Most research peptides are made by building the chain one amino acid at a time on a resin. Knowing the steps explains the impurity profile on a Certificate of Analysis.

Published 19 November 2026 · Last updated 19 November 2026

The idea in one paragraph

In solid-phase peptide synthesis the first amino acid is attached through its carboxyl group to an insoluble polymer bead (the resin). Each further residue is coupled to the free amine of the growing chain, and between steps the resin is simply washed, so excess reagents and by-products leave in the filtrate while the peptide stays on the bead. R. B. Merrifield introduced the approach in 1963. Behrendt et al. (2016) describe Fmoc solid-phase synthesis as today's method of choice, with high-quality Fmoc building blocks available at low cost because of the multiton production of therapeutic peptides by this route, and with many modified derivatives available as Fmoc building blocks.

The Fmoc/tBu cycle

The standard protocol described by Coin et al. (2007) uses Fmoc/tBu chemistry, carboxyl activation by aminium-derived coupling reagents, and PEG-modified polystyrene resins. Each residue added repeats the same cycle:

One cycle of Fmoc solid-phase synthesis, and what can go wrong at each stage
StageWhat happensWhat an imperfect step leaves behind
1. DeprotectionThe temporary Fmoc group is removed from the chain's N-terminal amine, usually with a base, exposing a free amine.If incomplete, the next residue is never added to that chain: a deletion sequence missing one residue.
2. WashReagents and the cleaved protecting group are washed off the resin.Poor washing can carry reagents into the next step.
3. CouplingThe next Fmoc amino acid, its carboxyl group activated, is coupled to the free amine. Side chains carry permanent protecting groups (tBu-type) that survive the cycle.If incomplete, some chains miss this residue (deletion sequence). Residues can also be added twice or racemise in rare cases.
4. WashExcess activated amino acid is removed.Carry-over of reagents.

Repeating the cycle for every residue gives a protected peptide on the resin. A 41-mer is 41 cycles, which is why small percentages lost per step compound along the chain. See common impurities in synthetic peptides for how deletion and truncation products show up in HPLC and mass-spectrometry data.

Difficult sequences and aggregation

Coin et al. (2007) identify aggregation of the growing peptide chain on the resin as the main cause of failure for peptide chemosynthesis. Bedford et al. (1992) measured deprotection peak profiles during Fmoc-polyamide continuous-flow synthesis as a measure of internal aggregation and correlated the results with amino-acid structure. As an example of what special techniques can do, Coin et al. show depsipeptide and pseudoproline units applied to an extremely difficult sequence, the Asn15 analogue of the WW domain FBP28, which they describe as impossible to obtain with the standard protocol.

A second well-documented side reaction involves aspartic acid. Mergler et al. (2003) studied aspartimide formation, a ring closure at Asp residues during Fmoc chemistry, using the model hexapeptide VKDGYI and measured aspartimide and related by-products by RP-HPLC. They report that 3-methylpent-3-yl protection of the Asp side chain improved the situation significantly, and that complete suppression was achieved with OtBu side-chain protection combined with Hmb backbone protection on the preceding glycine.

Cleavage: the step that creates new side products

At the end of the synthesis the peptide is cleaved from the resin and the permanent side-chain protecting groups are removed, usually in strong trifluoroacetic acid (TFA). King et al. (1990) report that the success of Fmoc synthesis is often limited by side reactions during this TFA cleavage and deprotection. The majority of those side reactions modify susceptible residues, such as Trp, Tyr, Met and Cys, with TFA-liberated side-chain protecting groups and linkers. Scavengers suppress them: the authors found that a mixture of 82.5% TFA, 5% phenol, 5% water, 5% thioanisole and 2.5% ethanedithiol (Reagent K) was maximally efficient in inhibiting a great variety of side reactions, and they demonstrated it on ten peptides of 20 to 50 residues.

After cleavage: purify, dry, supply as a salt

  1. Crude peptide. The cleaved material contains the target sequence plus deletion sequences, truncated chains, incompletely deprotected forms, and scavenger-related adducts.
  2. Purification. Reversed-phase HPLC separates the target from these related species; see reversed-phase HPLC of peptides. Fractions are pooled on the basis of analytical HPLC and mass spectrometry.
  3. Drying. Pooled fractions are freeze-dried (lyophilisation) to a powder.
  4. Salt form. Because TFA is used in cleavage and commonly in HPLC, the powder is usually a TFA salt, which is why net peptide content is lower than gross weight; see TFA and other counter-ions.

What this means when reading a COA

  • HPLC purity describes the share of detected peak area that belongs to the main peak; it does not say how much of the vial is water or counter-ion (purity vs content).
  • A mass-spectrometry result tests identity of the main species; deletion sequences differ from the target by the mass of the missing residue, so the target mass and a small neighbouring peak can both be present (check the mass spectrometry yourself).
  • Longer peptides need more cycles, so the impurity burden generally becomes harder to keep low as chain length grows.

Related

References

  1. Behrendt R, White P, Offer J (2016). Advances in Fmoc solid-phase peptide synthesis. J Pept Sci 22:4-27. PubMed 26785684 · DOI
  2. Coin I, Beyermann M, Bienert M (2007). Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences. Nat Protoc 2:3247-56. PubMed 18079725 · DOI
  3. Bedford J, Hyde C, Johnson T, et al. (1992). Amino acid structure and "difficult sequences" in solid phase peptide synthesis. Int J Pept Protein Res 40:300-7. PubMed 1478788 · DOI
  4. Mergler M, Dick F, Sax B, et al. (2003). The aspartimide problem in Fmoc-based SPPS. Part I. J Pept Sci 9:36-46. PubMed 12587881 · DOI
  5. King DS, Fields CG, Fields GB (1990). A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int J Pept Protein Res 36:255-66. PubMed 2279849 · DOI
  6. Merrifield RB. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc 1963;85(14):2149–2154. doi:10.1021/ja00897a025.

Frequently asked questions

What is solid-phase peptide synthesis?

A method in which the peptide is built residue by residue while anchored to an insoluble resin, so excess reagents can be washed away after each step. Fmoc/tBu chemistry is the most widely used version (Behrendt et al., 2016; Coin et al., 2007).

What does Fmoc stand for?

9-fluorenylmethoxycarbonyl, the temporary protecting group on the alpha-amine of each incoming amino acid (King et al., 1990).

Why do synthetic peptides contain TFA?

Trifluoroacetic acid is the usual reagent for cleaving the finished peptide from the resin and removing side-chain protecting groups, and it commonly stays with the purified peptide as the counter-ion in the final salt.

Why are some sequences hard to make?

Coin et al. (2007) identify aggregation of the growing chain as the main cause of failure in peptide chemosynthesis, and describe depsipeptide and pseudoproline units as tools for difficult sequences.

How long does a synthesis take?

It depends on the length and the instrument. As one published example, Coin et al. (2007) report that the 41-residue peptide CRF is obtained in approximately 80 working hours with their standard protocol.